Clinical Trial

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to develop and refine an integrated minimally invasive care pathway for resectable lung cancer in the immunotherapy era, establishing a novel precision perioperative immunotherapy paradigm encompassing original techniques and clinical applications.
Trial Details
NCT Number NCT07119190
Lead Sponsor Peking University People's Hospital
Collaborators: Beijing Municipal Health Commission
Conditions Non-Small Cell Lung Cancer
Enrollment 350 participants
Start Date 2025-08-06
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12